Works matching IS 03407004 AND DT 2020 AND VI 69 AND IP 11

Results: 21

Immune resilience in response to cancer therapy.

Published in:

2020

By:

Gicobi, Joanina K.;
Barham, Whitney;
Dong, Haidong

Publication type:

Editorial

Silent acute appendicitis revealed by PET-CT during treatment with ipilimumab and nivolumab: a new immune-related adverse event.

Published in:

2020

By:

Mangas, C.;
Leoni-Parvex, S.;
Spataro, V.

Publication type:

Letter

Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2403, doi. 10.1007/s00262-020-02674-w

By:

Li, Mingjia;
Spakowicz, Daniel;
Zhao, Songzhu;
Patel, Sandip H.;
Johns, Andrew;
Grogan, Madison;
Miah, Abdul;
Husain, Marium;
He, Kai;
Bertino, Erin M.;
Shields, Peter G.;
Wei, Lai;
Carbone, David P.;
Otterson, Gregory A.;
Presley, Carolyn J.;
Owen, Dwight H.

Publication type:

Article

Augmenting engineered T-cell strategies in solid cancers through epigenetic priming.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2169, doi. 10.1007/s00262-020-02661-1

By:

Nielsen, Aaraby Y.;
Ormhøj, Maria;
Traynor, Sofie;
Gjerstorff, Morten F.

Publication type:

Article

Clinicopathological factors associated with tumor-infiltrating lymphocyte reactivity in breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2381, doi. 10.1007/s00262-020-02633-5

By:

Lee, Heejae;
Kim, Young-Ae;
Kim, Youngho;
Park, Hye Seon;
Seo, Jeong-Han;
Lee, Hyun;
Gong, Gyungyub;
Lee, Hee Jin

Publication type:

Article

IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2371, doi. 10.1007/s00262-020-02629-1

By:

Zheng, Yujia;
Li, Yu;
Tang, Bo;
Zhao, Qitai;
Wang, Dan;
Liu, Yulin;
Guo, Mengxing;
Zhao, Song;
Qi, Yu;
Zhang, Yi;
Huang, Lan

Publication type:

Article

ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2345, doi. 10.1007/s00262-020-02627-3

By:

Zheng, Meng;
Zhou, Zhiling;
Tian, Xiangting;
Xiao, Dingzhang;
Hou, Xinghua;
Xie, Zhi;
Liang, Haidan;
Lin, Shuguang

Publication type:

Article

Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2319, doi. 10.1007/s00262-020-02626-4

By:

Michielon, Elisabetta;
López González, Marta;
Burm, Judith L. A.;
Waaijman, Taco;
Jordanova, Ekaterina S.;
de Gruijl, Tanja D.;
Gibbs, Susan

Publication type:

Article

Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2393, doi. 10.1007/s00262-020-02625-5

By:

Fröbom, Robin;
Berglund, Erik;
Berglund, David;
Nilsson, Inga-Lena;
Åhlén, Jan;
von Sivers, Karin;
Linder-Stragliotto, Christina;
Suenaert, Peter;
Karlsson-Parra, Alex;
Bränström, Robert

Publication type:

Article

Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2291, doi. 10.1007/s00262-020-02624-6

By:

Sapski, Sabrina;
Beha, Nadine;
Kontermann, Roland E.;
Müller, Dafne

Publication type:

Article

Differences in the sensitivity of classically and alternatively activated macrophages to TAK1 inhibitor-induced necroptosis.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2193, doi. 10.1007/s00262-020-02623-7

By:

Varga, Zsófia;
Molnár, Tamás;
Mázló, Anett;
Kovács, Ramóna;
Jenei, Viktória;
Kerekes, Krisztina;
Bácsi, Attila;
Koncz, Gábor

Publication type:

Article

Metabolomic profiling of tumor-infiltrating macrophages during tumor growth.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2357, doi. 10.1007/s00262-020-02622-8

By:

Umemura, Naoki;
Sugimoto, Masahiro;
Kitoh, Yusuke;
Saio, Masanao;
Sakagami, Hiroshi

Publication type:

Article

Infiltration of T cells promotes the metastasis of ovarian cancer cells via the modulation of metastasis-related genes and PD-L1 expression.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2275, doi. 10.1007/s00262-020-02621-9

By:

Wang, Jing-Jing;
Siu, Michelle Kwan-Yee;
Jiang, Yu-Xin;
Chan, David Wai;
Cheung, Annie Nga-Yin;
Ngan, Hextan Yuen-Sheung;
Chan, Karen Kar-Loen

Publication type:

Article

Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2233, doi. 10.1007/s00262-020-02620-w

By:

Ibrahim, Mohammed L.;
Lu, Chunwan;
Klement, John D.;
Redd, Priscilla S.;
Yang, Dafeng;
Smith, Alyssa D.;
Liu, Kebin

Publication type:

Article

Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2247, doi. 10.1007/s00262-020-02619-3

By:

Daiko, H.;
Marafioti, T.;
Fujiwara, T.;
Shirakawa, Y.;
Nakatsura, T.;
Kato, K.;
Puccio, I.;
Hikichi, T.;
Yoshimura, S.;
Nakagawa, T.;
Furukawa, M.;
Stoeber, K.;
Nagira, M.;
Ide, N.;
Kojima, T.

Publication type:

Article

Differences in PD-1 expression on CD8+ T-cells in chronic myeloid leukemia patients according to disease phase and TKI medication.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2223, doi. 10.1007/s00262-020-02617-5

By:

Lee, Min Young;
Park, Chan-Jeoung;
Cho, Young-Uk;
You, Eunkyoung;
Jang, Seongsoo;
Seol, Chang Ahn;
Seo, Eul-Ju;
Choi, Eun-Ji;
Lee, Je-Hwan

Publication type:

Article

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2209, doi. 10.1007/s00262-020-02613-9

By:

Cortellini, Alessio;
Tiseo, Marcello;
Banna, Giuseppe L.;
Cappuzzo, Federico;
Aerts, Joachim G. J. V.;
Barbieri, Fausto;
Giusti, Raffaele;
Bria, Emilio;
Cortinovis, Diego;
Grossi, Francesco;
Migliorino, Maria R.;
Galetta, Domenico;
Passiglia, Francesco;
Santini, Daniele;
Berardi, Rossana;
Morabito, Alessandro;
Genova, Carlo;
Mazzoni, Francesca;
Di Noia, Vincenzo;
Signorelli, Diego

Publication type:

Article

Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8<sup>+</sup> T cells.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2259, doi. 10.1007/s00262-020-02612-w

By:

Mousset, Charlotte M.;
Hobo, Willemijn;
de Ligt, Aafke;
Baardman, Sjoerd;
Schaap, Nicolaas P. M.;
Jansen, Joop H.;
van der Waart, Anniek B.;
Dolstra, Harry

Publication type:

Article

Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2305, doi. 10.1007/s00262-020-02609-5

By:

Long, Qilai;
Ma, Ai-Hong;
Zhang, Hongyong;
Cao, Zhixiu;
Xia, Roger;
Lin, Tzu-Yin;
Sonpavde, Guru P.;
de Vere White, Ralph;
Guo, Jianming;
Pan, Chong-Xian

Publication type:

Article

CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2333, doi. 10.1007/s00262-020-02589-6

By:

Xin, Chao;
Zhu, Jianmin;
Gu, Song;
Yin, Minzhi;
Ma, Jing;
Pan, Ci;
Tang, Jingyan;
Zhang, Peng;
Liu, Yang;
Bai, Xue-Feng;
Mo, Xi;
Xu, Min;
Zhu, Hua

Publication type:

Article

In vitro 4-1BB stimulation promotes expansion of CD8<sup>+</sup> tumor-infiltrating lymphocytes from various sarcoma subtypes.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2179, doi. 10.1007/s00262-020-02568-x

By:

Nielsen, Morten;
Krarup-Hansen, Anders;
Hovgaard, Dorrit;
Petersen, Michael Mørk;
Loya, Anand Chainsukh;
Westergaard, Marie Christine Wulff;
Svane, Inge Marie;
Junker, Niels

Publication type:

Article